SSREY (Swiss Re AG) Research & Development: $0 Mil (TTM As of Dec. 2025)


SSREY Swiss Re AG SSREY
63 GF Score
Price $38.99
GF Value $33.30
Valuation Modestly Overvalued
! 2 Warning Signs
View Full Analysis

What is Swiss Re AG Research & Development?

Swiss Re AG SSREY +1.14% 63 Research & Development is $0 Mil as of Dec. 2025. GuruFocus rates SSREY with a GF Score™ of 63/100 and a GF Value™ of $33.30 (Modestly Overvalued). The stock has 2 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Swiss Re AG's Research & Development for the six months ended in Dec. 2025 was $0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was $0 Mil.

Swiss Re AG  (OTCPK:SSREY) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Swiss Re AG Research & Development Related Terms

Swiss Re AG Research & Development Historical Data

* Premium members only.

The historical data trend for Swiss Re AG's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Swiss Re AG Research & Development Chart

Swiss Re AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Swiss Re AG Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
SSREY
63GF Score
Swiss Re AG SSREY
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Swiss Re AG Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $0 Mil mean?
Swiss Re AG (SSREY) has a Research & Development of $0 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on Swiss Re AG and its competitors.
Is Swiss Re AG's Research & Development too high?
Swiss Re AG's current Research & Development is $0 Mil. Overall, Swiss Re AG has a GF Score™ of 63/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Swiss Re AG's Research & Development compare to RGA and EG?
Swiss Re AG's Research & Development of $0 Mil can be compared against companies in the Insurance industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for an Insurance company?
A good Research & Development depends on the Insurance industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Swiss Re AG and its competitors. Swiss Re AG's current Research & Development is $0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Swiss Re AG stock overvalued right now?
Based on GuruFocus' analysis, Swiss Re AG (SSREY) is currently considered Modestly Overvalued. The stock's GF Value™ is $33.30, compared to a current price of $38.99 — trading 17.1% above its estimated fair value. The current Research & Development is $0 Mil. Swiss Re AG's overall GF Score™ is 63/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Swiss Re AG (SSREY), the current Research & Development is $0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Swiss Re AG (SSREY) Overvalued in 2026?

Based on GuruFocus' analysis, Swiss Re AG stock appears to be overvalued. The current stock price of $38.99 is trading 17.1% above its estimated GF Value™ of $33.30. GuruFocus considers Swiss Re AG to be Modestly Overvalued.

Key valuation signals for SSREY:

  • Research & Development: $0 Mil
  • GF Value™: $33.30 vs. price of $38.99 (17.1% above fair value)
  • GF Score™: 63/100 with 2 warning signs

No single metric tells the full story. See the SSREY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Swiss Re AG Business Description

Address Mythenquai 50/60, Zurich, CHE, 8022
Swiss Re is a reinsurer that has three core divisions: P&C reinsurance, life and health reinsurance, and corporate solutions. Swiss Re was founded in 1863 when the general manager of Helvetia sought to stem the flow of reinsurance premiums outside Switzerland. Moritz Grossmann argued he could cut the premiums paid to foreign firms, still make a profit, and pay mid-single-digit dividends. Swiss Re is now the second-largest reinsurer in the world by market capitalization, with 80 offices around the world and approximately 15,000 employees. While the business did lose its way in the early part of the millennium, led by an investment banker who heavily invested in securitizations, Swiss Re has recently focused on establishing quality within its three core divisions.
63GF Score

Get the complete analysis for SSREY

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$38.99
Price
$33.30
GF Value